Sumitomo Dainippon Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

Yoshinori Aihara

Andrew Simon Bell

Jeremy Besnard

Hidefumi Yoshinaga

Yohei Ikuma

Satoshi Adachi

Junya Ikeda

Harunobu Mitsunuma

Yuki Fujii

Masayuki Sakuma

The present invention relates to a medicament for treating neuropsychiatric diseases, comprising a compound of Formula (1): or a pharmaceutically acceptable salt thereof, as an active ingredient.

Substituted pyrazoles showing serotonin 5-HT receptor activity

Substituted lactams showing serotonin 5-HT receptor activity

The present invention relates to a compound represented by formula (1): the compound having antagonist activity against serotonin 5-HTreceptors and serotonin 5-HTreceptors; or a pharmaceutically acceptable salt of the compound. (In the formula, Z is a nitrogen atom and the like; Y is carbonyl and the like; m and n are 1 and the like; Rthrough R, Rthrough R, and Rthrough Rare a hydrogen atom and the like; Ris alkyl and the like; and Q is a specific bicyclic group.)

Aliphatic acid amide derivative

Condensed lactam derivative

Growing community of inventors

Nishinomiya, Japan

Yoshinori Aihara